NIFTY 50

Yogesh Mehta on January 2: Buy Infosys, & Sun Pharmaceutical; Sell Hero MotoCorp

Updated : January 02, 2019 12:43 PM IST

The latest analysis and commentary by stock market guru Yogesh Mehta, VP-Equity Advisory of Motilal Oswal on what is moving the markets today. Check out his top stock recommendations. He also answered viewer stock queries.

He spoke at length about Hero MotoCorp, Infosys, and Sun Pharmaceutical.

Recommending stock specific ideas, Mehta said, “Since Hero MotoCorp came out with bad set of numbers and technically also it has broken the support line, we are recommending to sell. Current price is around Rs 3,052 in future segment, keeping a little long stop loss of Rs 3,090 target could be in the range of Rs 3,000 or below that. The other one we are recommending is Infosys on buy side. Currently it is quoting at Rs 674, however rupee is not doing well for IT companies but Infosys’s technical chart looks good. Rs 674 is the current price, keeping a small stop loss of Rs 660 target could be in the range of Rs 695 to Rs 700 level. The third one is Sun Pharmaceutical on the long side. Rs 436 is the current price, keeping a stop loss of Rs 429, target could be in the range of Rs 450.”

Disclaimer: The views and investment tips expressed by investment experts on CNBCTV18.com are their own and not that of the website or its management. CNBCTV18.com advises users to check with certified experts before taking any investment decisions.
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV